Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant...
| Published in: | Human Vaccines & Immunotherapeutics |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-11-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2022.2065824 |
| _version_ | 1851862046982799360 |
|---|---|
| author | Ranjan K. Mohapatra Nahed A. El-Shall Ruchi Tiwari Firzan Nainu Venkataramana Kandi Ashish K. Sarangi Teroj Abdulrahman Mohammed Perumal Arumugam Desingu Chiranjib Chakraborty Kuldeep Dhama |
| author_facet | Ranjan K. Mohapatra Nahed A. El-Shall Ruchi Tiwari Firzan Nainu Venkataramana Kandi Ashish K. Sarangi Teroj Abdulrahman Mohammed Perumal Arumugam Desingu Chiranjib Chakraborty Kuldeep Dhama |
| author_sort | Ranjan K. Mohapatra |
| collection | DOAJ |
| container_title | Human Vaccines & Immunotherapeutics |
| description | The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant of SARS-CoV-2, Omicron has instilled serious uncertainties on the effectiveness of humoral adaptive immunity generated by COVID-19 vaccination or an active viral infection as well as the protection provided by antibody-based immunotherapies. Amidst such high public health concerns, the need to carry out booster vaccination has been emphasized. Current evidence reveals the importance of incorporating booster vaccination using several vaccine platforms, such as viral vector- and mRNA-based vaccines, as well as other platforms that are under explorative investigations. Further research is being conducted to assess the effectiveness and durability of protection provided by booster COVID-19 vaccination against Omicron and other SARS-CoV-2 variants. |
| format | Article |
| id | doaj-art-e4cb0e585b954bb883e8d645e650a926 |
| institution | Directory of Open Access Journals |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2022-11-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| spelling | doaj-art-e4cb0e585b954bb883e8d645e650a9262025-08-19T22:20:15ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-11-0118510.1080/21645515.2022.20658242065824Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An updateRanjan K. Mohapatra0Nahed A. El-Shall1Ruchi Tiwari2Firzan Nainu3Venkataramana Kandi4Ashish K. Sarangi5Teroj Abdulrahman Mohammed6Perumal Arumugam Desingu7Chiranjib Chakraborty8Kuldeep Dhama9Government College of EngineeringAlexandria UniversityUttar Pradesh Pandit DeenDayal Upadhyaya Pashu Chikitsa Vigyan Vishwavidyalaya Evam Go Anusandhan Sansthan (DUVASU)Hasanuddin UniversityPrathima Institute of Medical SciencesCenturion University of Technology and ManagementUniversity of DuhokIndian Institute of ScienceAdamas UniversityICAR-Indian Veterinary Research InstituteThe emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant of SARS-CoV-2, Omicron has instilled serious uncertainties on the effectiveness of humoral adaptive immunity generated by COVID-19 vaccination or an active viral infection as well as the protection provided by antibody-based immunotherapies. Amidst such high public health concerns, the need to carry out booster vaccination has been emphasized. Current evidence reveals the importance of incorporating booster vaccination using several vaccine platforms, such as viral vector- and mRNA-based vaccines, as well as other platforms that are under explorative investigations. Further research is being conducted to assess the effectiveness and durability of protection provided by booster COVID-19 vaccination against Omicron and other SARS-CoV-2 variants.http://dx.doi.org/10.1080/21645515.2022.2065824sars-cov-2omicron variantb.1.1.529vaccinesbooster dosesenhancing immunityprotection |
| spellingShingle | Ranjan K. Mohapatra Nahed A. El-Shall Ruchi Tiwari Firzan Nainu Venkataramana Kandi Ashish K. Sarangi Teroj Abdulrahman Mohammed Perumal Arumugam Desingu Chiranjib Chakraborty Kuldeep Dhama Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update sars-cov-2 omicron variant b.1.1.529 vaccines booster doses enhancing immunity protection |
| title | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
| title_full | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
| title_fullStr | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
| title_full_unstemmed | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
| title_short | Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update |
| title_sort | need of booster vaccine doses to counteract the emergence of sars cov 2 variants in the context of the omicron variant and increasing covid 19 cases an update |
| topic | sars-cov-2 omicron variant b.1.1.529 vaccines booster doses enhancing immunity protection |
| url | http://dx.doi.org/10.1080/21645515.2022.2065824 |
| work_keys_str_mv | AT ranjankmohapatra needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT nahedaelshall needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT ruchitiwari needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT firzannainu needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT venkataramanakandi needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT ashishksarangi needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT terojabdulrahmanmohammed needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT perumalarumugamdesingu needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT chiranjibchakraborty needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate AT kuldeepdhama needofboostervaccinedosestocounteracttheemergenceofsarscov2variantsinthecontextoftheomicronvariantandincreasingcovid19casesanupdate |